Knockout of mitochondrial thioredoxin reductase stabilizes prolyl hydroxylase 2 and inhibits tumor growth and tumor-derived angiogenesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Antioxidants & Redox Signaling, 22, 11, S. 938-950
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg, Mary Ann Liebert
- (wann)
-
2015
- Urheber
-
Hellfritsch, Juliane
Kirsch, Julian
Schneider, Manuela
Fluege, Tamara
Wortmann, Markus
Frijhoff, Jeroen
Dagnell, Markus
Fey, Theres
Esposito, Irene
Kölle, Pirkko
Pogoda, Kristin
Angeli, José Pedro Friedmann
Ingold, Irina
Kuhlencordt, Peter
Östman, Arne
Pohl, Ulrich
Conrad, Marcus
Beck, Heike
- DOI
-
10.1089/ars.2014.5889
- URN
-
urn:nbn:de:bvb:384-opus4-807172
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hellfritsch, Juliane
- Kirsch, Julian
- Schneider, Manuela
- Fluege, Tamara
- Wortmann, Markus
- Frijhoff, Jeroen
- Dagnell, Markus
- Fey, Theres
- Esposito, Irene
- Kölle, Pirkko
- Pogoda, Kristin
- Angeli, José Pedro Friedmann
- Ingold, Irina
- Kuhlencordt, Peter
- Östman, Arne
- Pohl, Ulrich
- Conrad, Marcus
- Beck, Heike
- Universität Augsburg, Mary Ann Liebert
Entstanden
- 2015
Ähnliche Objekte (12)
Primary tumor–derived systemic nANGPTL4 inhibits metastasis
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Influence of mitochondrial thioredoxin reductase on KrasG12D-mediated pancreatic carcinogenesis
Tunicamycin potently inhibits tumor necrosis factor-induced hepatocyte apoptosis
Endothelial cell-specific deletion of the mitochondrial thioredoxin reductase impairs vascular remodelling
Loss of mitochondrial thioredoxin reductase delays angiogenic switch and impairs tumour growth
Loss of mitochondrial thioredoxin reductase delays angiogenic switch and impairs tumour growth
Hyperglycemia-induced thioredoxin reductase degradation accelerates ferroptotic cell death propagation in diabetic renal tubules
IAP antagonization promotes inflammatory destruction of vasculature endothelium and inhibits tumor growth
ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth
The role of hif prolyl hydroxylases (PHD-2 and PHD-4) in tumor progression
Über die diagnostische Bedeutung der Serum-Glutathion-Reductase für die Erkennung maligner Tumoren
Primary tumor–derived systemic nANGPTL4 inhibits metastasis
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Influence of mitochondrial thioredoxin reductase on KrasG12D-mediated pancreatic carcinogenesis
Tunicamycin potently inhibits tumor necrosis factor-induced hepatocyte apoptosis
Endothelial cell-specific deletion of the mitochondrial thioredoxin reductase impairs vascular remodelling
Loss of mitochondrial thioredoxin reductase delays angiogenic switch and impairs tumour growth
Loss of mitochondrial thioredoxin reductase delays angiogenic switch and impairs tumour growth
Hyperglycemia-induced thioredoxin reductase degradation accelerates ferroptotic cell death propagation in diabetic renal tubules
IAP antagonization promotes inflammatory destruction of vasculature endothelium and inhibits tumor growth
ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth
The role of hif prolyl hydroxylases (PHD-2 and PHD-4) in tumor progression
Über die diagnostische Bedeutung der Serum-Glutathion-Reductase für die Erkennung maligner Tumoren
Primary tumor–derived systemic nANGPTL4 inhibits metastasis
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Influence of mitochondrial thioredoxin reductase on KrasG12D-mediated pancreatic carcinogenesis
Tunicamycin potently inhibits tumor necrosis factor-induced hepatocyte apoptosis
Endothelial cell-specific deletion of the mitochondrial thioredoxin reductase impairs vascular remodelling
Loss of mitochondrial thioredoxin reductase delays angiogenic switch and impairs tumour growth
Loss of mitochondrial thioredoxin reductase delays angiogenic switch and impairs tumour growth
Hyperglycemia-induced thioredoxin reductase degradation accelerates ferroptotic cell death propagation in diabetic renal tubules
IAP antagonization promotes inflammatory destruction of vasculature endothelium and inhibits tumor growth
ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth
The role of hif prolyl hydroxylases (PHD-2 and PHD-4) in tumor progression